These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9873477

  • 1. General construction pattern of histamine H3-receptor antagonists: change of a paradigm.
    Stark H, Ligneau X, Arrang JM, Schwartz JC, Schunack W.
    Bioorg Med Chem Lett; 1998 Aug 04; 8(15):2011-6. PubMed ID: 9873477
    [Abstract] [Full Text] [Related]

  • 2. Substituted N-phenylcarbamates as histamine H3 receptor antagonists with improved in vivo potency.
    Reidemeister S, Stark H, Ligneau X, Ganellin CR, Schwartz JC, Schunack W.
    Pharmazie; 2000 Feb 04; 55(2):83-6. PubMed ID: 10723763
    [Abstract] [Full Text] [Related]

  • 3. Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds.
    Stark H, Sadek B, Krause M, Hüls A, Ligneau X, Ganellin CR, Arrang JM, Schwartz JC, Schunack W.
    J Med Chem; 2000 Oct 19; 43(21):3987-94. PubMed ID: 11052804
    [Abstract] [Full Text] [Related]

  • 4. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
    Krause M, Ligneau X, Stark H, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1998 Oct 08; 41(21):4171-6. PubMed ID: 9767653
    [Abstract] [Full Text] [Related]

  • 5. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A, Kiec-Kononowicz K, Stark H, Motyl M, Reidemeister S, Ganellin CR, Ligneau X, Schwartz JC, Schunack W.
    J Med Chem; 1999 Feb 25; 42(4):593-600. PubMed ID: 10052966
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
    Stark H, Hüls A, Ligneau X, Purand K, Pertz H, Arrang JM, Schwartz JC, Schunack W.
    Arch Pharm (Weinheim); 1998 Jun 25; 331(6):211-8. PubMed ID: 9713254
    [Abstract] [Full Text] [Related]

  • 8. New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.
    Sasse A, Sadek B, Ligneau X, Elz S, Pertz HH, Luger P, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2000 Aug 24; 43(17):3335-43. PubMed ID: 10966752
    [Abstract] [Full Text] [Related]

  • 9. Progress in the proxifan class: heterocyclic congeners as novel potent and selective histamine H(3)-receptor antagonists.
    Grassmann S, Sadek B, Ligneau X, Elz S, Ganellin CR, Arrang JM, Schwartz JC, Stark H, Schunack W.
    Eur J Pharm Sci; 2002 May 24; 15(4):367-78. PubMed ID: 11988398
    [Abstract] [Full Text] [Related]

  • 10. Novel histamine H3-receptor antagonists with benzyl ether structure or related moieties: synthesis and structure-activity relationships.
    Hüls A, Purand K, Stark H, Reidemeister S, Ligneau X, Arrang JM, Schwartz JC, Schunack W.
    Arch Pharm (Weinheim); 1996 May 24; 329(8-9):379-85. PubMed ID: 8915097
    [Abstract] [Full Text] [Related]

  • 11. Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.
    Pelloux-Léon N, Fkyerat A, Piripitsi A, Tertiuk W, Schunack W, Stark H, Garbarg M, Ligneau X, Arrang JM, Schwartz JC, Ganellin CR.
    J Med Chem; 2004 Jun 03; 47(12):3264-74. PubMed ID: 15163206
    [Abstract] [Full Text] [Related]

  • 12. Importance of the lipophilic group in carbamates having histamine H3-receptor antagonist activity.
    Kieć-Kononowicz K, Wiecek M, Sasse A, Ligneau X, Elz S, Ganellin CR, Schwartz JC, Stark H, Schunack W.
    Pharmazie; 2000 May 03; 55(5):349-55. PubMed ID: 11828613
    [Abstract] [Full Text] [Related]

  • 13. Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists.
    Meier G, Apelt J, Reichert U, Grassmann S, Ligneau X, Elz S, Leurquin F, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    Eur J Pharm Sci; 2001 Jun 03; 13(3):249-59. PubMed ID: 11384847
    [Abstract] [Full Text] [Related]

  • 14. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G, Krause M, Hüls A, Ligneau X, Pertz HH, Arrang JM, Ganellin CR, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2004 May 06; 47(10):2678-87. PubMed ID: 15115409
    [Abstract] [Full Text] [Related]

  • 15. Theophylline derivatives as potential histamine H3-receptor antagonists.
    Kieć-Kononowicz K, Cegła MT.
    Pharmazie; 1998 Aug 06; 53(8):518-21. PubMed ID: 9741061
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups.
    Mor M, Bordi F, Silva C, Rivara S, Zuliani V, Vacondio F, Morini G, Barocelli E, Ballabeni V, Impicciatore M, Plazzi PV.
    Farmaco; 2000 Jan 06; 55(1):27-34. PubMed ID: 10755228
    [Abstract] [Full Text] [Related]

  • 17. Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.
    Stark H, Hüls A, Ligneau X, Arrang JM, Schwartz JC, Schunack W.
    Pharmazie; 1997 Jul 06; 52(7):495-500. PubMed ID: 9266588
    [Abstract] [Full Text] [Related]

  • 18. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T, Ligneau X, Pertz HH, Ganellin CR, Arrang JM, Schwartz JC, Schunack W, Stark H.
    J Med Chem; 2003 Apr 10; 46(8):1523-30. PubMed ID: 12672253
    [Abstract] [Full Text] [Related]

  • 19. Piperidine-containing histamine H3 receptor antagonists of the carbamate series: the alkyl derivatives.
    Lazewska D, Kieć-Kononowicz K, Elz S, Pertz HH, Stark H, Schunack W.
    Pharmazie; 2005 Jun 10; 60(6):403-10. PubMed ID: 15997826
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.
    De Esch IJ, Gaffar A, Menge WM, Timmerman H.
    Bioorg Med Chem; 1999 Dec 10; 7(12):3003-9. PubMed ID: 10658607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.